Drug Development and Clinical Trial Participation Webinar

Drug Development and Clinical Trial Participation – A Webinar for the Rare Disease Community 

hosted by                    

CureDuchenne was pleased to host the “Drug Development and Clinical Trial Participation – A Webinar for the Rare Disease Community” on Friday, September 13.  The webinar was an opportunity for parents to learn about the drug development process – from the pre-clinical phase to the clinical phase to the post approval phase and the regulatory process guiding these phases – from industry experts.

Click here to watch the recording of the webinar. You’ll be prompted to enter your name and email address to view the recording.

Click here for a glossary of terms

Our presenters were:

Carl Morris, Ph.D.

Director, Protein Therapeutics and Muscle Biology, Pfizer Rare Disease Research Unit

Lawrence Charnas M.D., Ph.D.

Director & Head, Discovery Medicine at Shire plc

Jennifer Eaddy

Associate Director, Regulatory Affairs, Genzyme

The session was moderated by Michael Kelly, Ph.D., Chief Scientific Officer at CureDuchenne.